The signature of serum lipids remodeling in recent-onset type 2 diabetes mellitus treated with dulaglutide and liraglutide.

Detalles Bibliográficos
Publicado en:International Journal of Diabetes in Developing Countries Vol. 45; no. 4; pp. 908 - 919
Autores principales: Du, Juan, Ge, Xiaoxu, Li, Wenyi, Wang, Jiajia, Zhang, Zhongxiao, Jiang, Xiaohong, Shao, Kan, Peng, Wenfang, Wang, Xingyun, Guo, Xirong, Huang, Shan
Formato: research tables/charts Journal Article
Publicado: Springer Nature Dec2025
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=189055516&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 189055516
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        09733930
        259E
      jtl: International Journal of Diabetes in Developing Countries
      issn: 09733930
      maglogo: N
    pubinfo:
      dt: Dec2025
      vid: 45
      iid: 4
      pid: 237
      pub: Springer Nature
      place: New York, New York
    artinfo:
      ui:
        189055516
        180247246
        189055516
        189055516
        10.1007/s13410-024-01408-3
        189055516
      ppf: 908
      ppct: 11
      formats:
        fmt:
          – @attributes:
              type: T
          – @attributes:
              type: P
      tig:
        atl: The signature of serum lipids remodeling in recent-onset type 2 diabetes mellitus treated with dulaglutide and liraglutide.
      aug:
        au:
          Du, Juan
          Ge, Xiaoxu
          Li, Wenyi
          Wang, Jiajia
          Zhang, Zhongxiao
          Jiang, Xiaohong
          Shao, Kan
          Peng, Wenfang
          Wang, Xingyun
          Guo, Xirong
          Huang, Shan
        affil: https://ror.org/0220qvk04 Endocrinology Department, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
      sug:
        subj:
          Diabetes Mellitus, Type 2 Drug Therapy
          Glucagon-Like Peptide-1 Receptor Agonists Therapeutic Use
          Lipids Blood
          Human China
          Funding Source
          China
          Case Control Studies
          Liquid Chromatography-Mass Spectrometry
          T-Tests
          Mann-Whitney U Test
          Pearson's Correlation Coefficient
          Chi Square Test
          Data Analysis Software
          Male
          Female
          Adult
          Middle Age
          Body Mass Index
          Glycated Hemoglobin Blood
          Fatty Acids Blood
          Lipoproteins, LDL
          Lipoproteins, HDL
          Adult: 19-44 years
          Middle Aged: 45-64 years
          Male
          Female
      pubtype: Academic Journal
      doctype:
        research
        tables/charts
        Journal Article
      ougenre: Article
      ab:
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N